41
Participants
Start Date
March 31, 1999
Primary Completion Date
November 30, 2006
Study Completion Date
March 31, 2012
Herceptin
Given intravenously once weekly for 12 weeks prior to surgery.
Taxol
Given intravenously every 3 weeks (weeks 1, 4, 7, and 10) before surgery.
Adriamycin
Given every three weeks for 12 weeks after surgery.
Cytoxan
Given every three weeks for 12 weeks after surgery.
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
Collaborators (2)
Dana-Farber Cancer Institute
OTHER
Genentech, Inc.
INDUSTRY
Bristol-Myers Squibb
INDUSTRY
Massachusetts General Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER
Harvard Vanguard Medical Associates
OTHER
Brigham and Women's Hospital
OTHER
Harold J. Burstein, MD, PhD
OTHER